These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 8503552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Allergic bronchial asthma due to Dermatophagoides pteronyssinus hypersensitivity can be efficiently treated by inoculation of allergen-antibody complexes.
    Machiels JJ, Somville MA, Lebrun PM, Lebecque SJ, Jacquemin MG, Saint-Remy JM.
    J Clin Invest; 1990 Apr; 85(4):1024-35. PubMed ID: 2318962
    [Abstract] [Full Text] [Related]

  • 3. Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae.
    Ferrer A, García-Sellés J.
    J Investig Allergol Clin Immunol; 2003 Apr; 13(4):244-51. PubMed ID: 14989113
    [Abstract] [Full Text] [Related]

  • 4. Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of dermatophagoides pteronyssinus.
    Ibero M, Castillo MJ.
    J Investig Allergol Clin Immunol; 2006 Apr; 16(3):194-202. PubMed ID: 16784014
    [Abstract] [Full Text] [Related]

  • 5. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB.
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [Abstract] [Full Text] [Related]

  • 6. Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study.
    García-Robaina JC, Sánchez I, de la Torre F, Fernández-Caldas E, Casanovas M.
    J Allergy Clin Immunol; 2006 Nov; 118(5):1026-32. PubMed ID: 17088125
    [Abstract] [Full Text] [Related]

  • 7. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D, Akmanlar N, Güneşer S, Burgut R, Yilmaz M, Buğdayci R, Aksungur P.
    Allergol Immunopathol (Madr); 1999 Nov; 27(6):309-17. PubMed ID: 10611556
    [Abstract] [Full Text] [Related]

  • 8. Double-blind and placebo-controlled study to assess efficacy and safety of a modified allergen extract of Dermatophagoides pteronyssinus in allergic asthma.
    Ameal A, Vega-Chicote JM, Fernández S, Miranda A, Carmona MJ, Rondón MC, Reina E, García-González JJ.
    Allergy; 2005 Sep; 60(9):1178-83. PubMed ID: 16076305
    [Abstract] [Full Text] [Related]

  • 9. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F, Daza JC, Almeda E.
    J Investig Allergol Clin Immunol; 2003 Sep; 13(2):108-17. PubMed ID: 12968395
    [Abstract] [Full Text] [Related]

  • 10. [The effect of local specific bronchial immunotherapy (LIT) on specific and non-specific bronchial hyperreactivity in patients with bronchial asthma sensitive to housedust mites].
    Zietkowski Z, Rogalewska AM, Bodzenta-ŁLukaszyk A.
    Pol Merkur Lekarski; 2000 Oct; 9(52):645-7. PubMed ID: 11144048
    [Abstract] [Full Text] [Related]

  • 11. Specific down-regulation of anti-allergen IgE and IgG antibodies in humans associated with injections of allergen-specific antibody complexes.
    Jacquemin MG, Saint-Remy JM.
    Ther Immunol; 1995 Feb; 2(1):41-52. PubMed ID: 7553070
    [Abstract] [Full Text] [Related]

  • 12. Enzyme-potentiated desensitization in children with asthma and mite allergy: a double-blind study.
    Cantani A, Ragno V, Monteleone MA, Lucenti P, Businco L.
    J Investig Allergol Clin Immunol; 1996 Feb; 6(4):270-6. PubMed ID: 8844506
    [Abstract] [Full Text] [Related]

  • 13. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus).
    Van Bever HP, Stevens WJ.
    Eur Respir J; 1992 Mar; 5(3):318-22. PubMed ID: 1572445
    [Abstract] [Full Text] [Related]

  • 14. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
    Lue KH, Lin YH, Sun HL, Lu KH, Hsieh JC, Chou MC.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
    [Abstract] [Full Text] [Related]

  • 15. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N, Scheinmann P, Fadel R, Combebias A, Andre C.
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [Abstract] [Full Text] [Related]

  • 16. Repeated aerosol exposure to small doses of allergen. A model for chronic allergic asthma.
    Arshad SH, Hamilton RG, Adkinson NF.
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1900-6. PubMed ID: 9620925
    [Abstract] [Full Text] [Related]

  • 17. Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics.
    Paggiaro PL, Dente FL, Morelli MC, Bancalari L, Di Franco A, Giannini D, Vagaggini B, Bacci E, Fabbri LM, Giuntini C.
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1447-51. PubMed ID: 8004297
    [Abstract] [Full Text] [Related]

  • 18. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB.
    Int Arch Allergy Immunol; 2012 Jun; 157(3):288-98. PubMed ID: 22041501
    [Abstract] [Full Text] [Related]

  • 19. [Preventive immunotherapy].
    Boquete M, Carballada F, Expósito F, González A.
    Allergol Immunopathol (Madr); 2000 Jun; 28(3):89-93. PubMed ID: 10867376
    [Abstract] [Full Text] [Related]

  • 20. The respiratory effects of reduction of mite allergen in the bedrooms of asthmatic children--a double-blind controlled trial.
    Carswell F, Birmingham K, Oliver J, Crewes A, Weeks J.
    Clin Exp Allergy; 1996 Apr; 26(4):386-96. PubMed ID: 8732235
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.